Mirae Asset Global Etfs Holdings Ltd. Biomarin Pharmaceutical Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 42,535 shares of BMRN stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,535
Previous 52,489
18.96%
Holding current value
$2.36 Million
Previous $3.71 Million
36.98%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
675Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.06 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$876 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$840 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$683 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...